$0.79
▲ +0.1% Today
as of Jul 22, 16:55 ET
Last 30 days
Recent Press Releases & News
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Tenaya Therapeutics Names Eric Hyllengren CFO
Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer
Overview
52-week range
$0.52
$2.35
15% of range
Avg surprise (last 3)
-1.1%
Avg reaction (last 2)
+0.6%
50% positive
Latest IV / EM
1119%
EM ±81.0% · $1 · Jul 17
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 6, 2026 | Mar/2026 | $-0.09 | $-0.09 | 0.0% | +62.5% | +4.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.12 | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | $-0.14 | $-0.20 | +30.0% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $-0.24 | $-0.18 | -33.3% | — | -3.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.30 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.34 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.40 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.39 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.45 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 5, 2026 | Jun/2026 | OTHER | -$0.08 | -$0.14 | +42.9% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $225,000 | — | — | — | $0 | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-20M | — | $-21M | $-24M | $-28M | — | $-27M | $-31M |
| Net income | $-19M | — | $-20M | $-23M | $-27M | — | $-26M | $-29M |
| EPS (diluted) | $-0.09 | — | $-0.12 | $-0.14 | $-0.24 | — | $-0.30 | $-0.34 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $81M | $101M | $56M | $63M | $54M | $4M | $8M | $58M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $97M | $106M | $61M | $76M | $94M | $67M | $85M | $105M |
| Total assets | $135M | $147M | $105M | $122M | $144M | $120M | $141M | $163M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $29M | $24M | $22M | $22M | $25M | $27M | $28M | $29M |
| Total equity | $106M | $123M | $83M | $100M | $119M | $93M | $113M | $134M |